Blocklisting Six Monthly Retu

RNS Number : 4325O
Hutchison China Meditech Limited
29 June 2010
 



 

 

 

Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

 

Blocklisting Six Monthly Return

 

 

London: Tuesday, 29 June 2010: Chi-Med announces the following blocklisting six monthly return:

 

1.

Name of applicant:

 


Hutchison China MediTech Limited

2.

Name of scheme:

 


Hutchison China MediTech Limited Share Option Scheme

 

3.

Period of return:                                 

 


From 29 December 2009 to 28 June 2010

 

4.

Balance under scheme from previous return:

 


2,493,553 ordinary shares of US$1 each

 

5.

The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return:

 


Nil

6.

Number of securities issued/allotted under scheme during period:


455,444 ordinary shares of US$1 each

7.

Balance under scheme not yet issued/allotted at end of the period:

 


2,038,109 ordinary shares of US$1 each

8.

Number and class of securities originally listed and the date of admission:

 


2,560,606 ordinary shares of US$1 each admitted on 26 June 2007

9.

Total number of securities in issue at the end of the period:


51,734,618 ordinary shares of US$1 each

Name of contact:

 


Christian Hogg

Address of contact:

 


21/F., Hutchison House, 10 Harcourt Road, Hong Kong

 

Telephone number of contact:

 


+852 2121 8200

 

 

 

Ends

 

 

Enquiries

 

    Chi-Med

    Christian Hogg, CEO

Telephone: +852 2121 8200

    Citigate Dewe Rogerson

    Anthony Carlisle

    David Dible

Telephone: +44 (0) 20 7638 9571

+44 (0) 7973 611 888

+44 (0) 7967 566 919

 

    Lazard & Co., Limited

    Paul Gismondi

    Nick Fowler

Telephone: +44 (0) 20 7187 2000

 

 

 

 

 

About Chi-Med

 

Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006.  It is focused on researching, developing, manufacturing, and selling pharmaceuticals and health oriented consumer products.

 

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRUKVURRBANUAR
UK 100